What Cigna Ventures does

Cigna Ventures is the strategic corporate venture capital arm of The Cigna Group, established in September 2018 with an initial $250 million capital commitment and subsequently scaled with an additional $450 million in March 2022, bringing total committed capital to $700 million. The fund invests in early and growth-stage companies developing whole-person health services and technology solutions, with a stated focus on broadening access to care, enhancing support, and driving better value. It maintains investment autonomy while remaining strategically aligned to The Cigna Group's healthcare mission.

The fund operates a capital-plus-distribution model rather than a traditional financial-return-only strategy. It deploys equity into portfolio companies and then activates commercial integration through Evernorth Health Services, The Cigna Group's health services segment, which provides portfolio companies access to health plan distribution, the Digital Health Formulary, and 170M+ customer relationships across 30+ countries. The fund reports a 92% conversion rate from investment to active strategic partnership and has produced multiple liquidity events, including the 2021 MDLIVE acquisition by Evernorth, the 2021 Headspace/Ginger merger forming Headspace Health, and the May 2025 IPO of portfolio company Omada Health on Nasdaq under ticker OMDA.

The current portfolio spans 24 companies across behavioral health (Headspace Health, NOCD, Alma, Octave, Valera Health), chronic condition management (Omada Health, Monogram Health), virtual care (MDLIVE, 9amHealth), kidney care (Cricket Health, InterWell Health), specialty care (Cleerly, Zerigo Health, Babyscripts, Visana Health), and healthcare AI and analytics (Autonomize AI, Arcadia, Prognos Health, GNS Healthcare, Buoy Health). Operations are run by a lean team of seven to eight investment professionals led by Head of Cigna Group Ventures Craig Cimini, supported by Senior Principals Rachel Anderson and Matthew Blum, Principals Amir Debourou, Nikolas Koenning, and AJ Shimoga, and Associate Olivia Bruno, all based in Bloomfield, Connecticut.

Name

Cigna Ventures

Legal name

The Cigna Group Ventures

Website

https://www.cignaventures.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Cigna Ventures is the $700M strategic corporate venture arm of The Cigna Group, founded in 2018 to invest in early and growth-stage healthcare technology and services companies. It pairs equity capital with distribution access to 170M+ Cigna customers across 24 portfolio investments.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Healthcare venture capital
• Corporate venture capital
• Digital health investment
• Healthcare startup funding
• Growth stage investing

Headquarters

HQ city

Bloomfield

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Investment Returns: As a strategic corporate venture fund, Cigna Ventures generates returns through equity appreciation in portfolio companies, exits via acquisitions and IPOs, and strategic value creation through partnerships that benefit The Cigna Group's core health services business.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Cigna Ventures is the strategic corporate venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. It deploys capital alongside strategic partnership opportunities, providing portfolio companies with access to The Cigna Group's resources, customer relationships, and distribution channels through Evernorth Health Services.

Product overview

The Cigna Group Ventures operates as a strategic venture capital fund that invests in early and growth-stage healthcare companies. Rather than a unified product platform, the offering consists of the investment fund itself combined with strategic partnership opportunities and access to The Cigna Group's 170M+ global customers. The portfolio spans multiple healthcare verticals including behavioral health (Headspace Health, NOCD, Alma, Octave), chronic condition management (Omada Health, Monogram Health), virtual care (MDLive, 9amHealth), healthcare AI/analytics (Autonomize AI, Arcadia, Prognos Health, Buoy), kidney care (InterWell Health, Cricket Health), and specialty care (Cleerly, Zerigo Health, Babyscripts, Valera Health, Visana Health). The fund provides capital investment along with partnership opportunities, operational support, and market access through The Cigna Group's ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

• The Cigna Group Ventures (Strategic Venture Capital Fund) Strategic venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. Provides capital, strategic partnerships, and access to The Cigna Group's 170M+ customer relationships and Evernorth Health Services distribution network. Manages $700M AUM across 24 investments with 92% resulting in active strategic partnerships.
• Portfolio Companies Strategic Partnership Program A strategic partnership offering that provides portfolio companies with access to The Cigna Group's healthcare ecosystem, including Evernorth Health Services distribution channels, Digital Health Formulary placement, integration with Cigna's 170M+ customer base, and operational support. The program spans 20+ portfolio companies across behavioral health, chronic condition management, virtual care, healthcare AI, and specialty care verticals.

Quantifiable outcome

• 92% of investments result in active strategic partnerships with portfolio companies
• +3 more outcomes

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• The Cigna GroupcoreStrategic or Co-development PartnerCigna Ventures is the strategic venture fund of The Cigna Group, a leading global health service company. The fund maintains strategic alignment with The Cigna Group while maintaining investment autonomy.
• Evernorth Health ServicescoreStrategic or Co-development PartnerEvernorth Health Services is The Cigna Group's health services segment and serves as a key integration point for portfolio companies, providing distribution and partnership opportunities for digital health solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Optum Ventures: The corporate venture arm of UnitedHealth Group/Optum investing in early- and growth-stage healthcare companies with strategic alignment to Optum's payer and care delivery platform. Most direct comparable to Cigna Ventures given similar size, mandate, and parent-distribution advantage.
• CVS Health Ventures: Corporate venture fund of CVS Health investing in healthcare startups aligned with CVS's pharmacy, payer, and care delivery strategy. Directly comparable in mandate, structure, and parent-company strategic distribution model.
• Kaiser Permanente Ventures: Strategic venture arm of Kaiser Permanente investing in healthcare technology and services companies that align with KP's integrated care model. Comparable as another large health-system-affiliated CVC with strategic-only capital and co-investment history alongside Cigna Ventures (e.g., NOCD).
• Echo Health Ventures: A strategic healthcare investment platform formed by Cambia Health Solutions and Mosaic Health Solutions, investing across payer, provider, and digital health. Highly comparable CVC model with strategic LP backing and similar check sizes and themes.
• Humana: Humana deploys strategic venture capital through its corporate development and investment arm into senior-focused, value-based care, and digital health companies. Direct peer in the payer-CVC landscape, with documented co-investment activity alongside Cigna Ventures (e.g., Monogram, Buoy Health).

Emerging players

• 7wireVentures: An early-stage healthcare venture firm focused on digital health and consumer-centric care models. Repeated co-investor with Cigna Ventures across NOCD and 9amHealth, making it a closely aligned emerging player in the same investment themes.
• Frist Cressey Ventures: Healthcare-focused venture firm with ~$1B AUM across funds targeting early-stage companies using AI to reduce costs and improve care delivery. Cigna Ventures is a strategic LP in FCV's $425M Fund IV, positioning FCV as a closely aligned emerging player and ecosystem partner.
• MemorialCare Innovation Fund: The strategic venture arm of MemorialCare Health System investing in healthcare technology and care delivery startups. Documented co-investor with Cigna Ventures (e.g., AristaMD Series B lead), functioning as a smaller, regionally anchored emerging peer.

Broad incumbents

• Andreessen Horowitz (a16z Bio + Health): A large, established venture firm with dedicated bio/health and healthcare funds investing across digital health, biotech, and care delivery. Functions as a broad incumbent that competes with Cigna Ventures for healthcare deals at much larger fund and check sizes.
• General Catalyst: A global venture firm with a deep healthcare practice investing across health systems, digital health, and care delivery. Competes with Cigna Ventures for healthcare AI and digital health opportunities and brings broader platform and founder network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/craig-cimini-6405b211

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments27 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cigna Ventures